Ads
related to: b-cell chronic lymphocytic leukemia treatment- CLL/SLL Therapy Option
Learn About This CLL/SLL Treatment
Your Patients On The HCP Site.
- Contact A Representative
Access CLL/SLL Support
From An HCP Representative.
- Long-Term Study Data
View The Study Design Data For
This CLL/SLL Treatment.
- Learn How Treatment Works
Read How This Therapy May Help
Your Patients With CLL/SLL.
- Dosing Information
View A CLL/SLL Treatment Option
With Flexible Dosing Options.
- Efficacy Data
Explore The Efficacy Data For
This CLL/SLL Therapy Option.
- CLL/SLL Therapy Option
Search results
Chronic Lymphocytic Leukemia: Slow-Appearing Symptoms
Verywell Health via Yahoo News· 10 months agoNew therapies are transforming treatment Halfpoint Images / Getty Images Medically reviewed by...
What Is Leukemia?
Verywell Health via Yahoo News· 1 year agoLeukemia is a form of blood cancer that starts in your bone marrow, the spongy tissue inside your bones. It occurs when abnormal cells grow too fast and...
Bristol Myers (BMY) Gets FDA Nod for Breyanzi's Label Expansion
Zacks via Yahoo Finance· 2 months agoBristol Myers (BMY) obtains FDA approval for the label expansion of CAR T cell therapy, Breyanzi,...
Roche's (RHHBY) Combination Therapy Meets Goal in Lymphoma Study
Zacks via Yahoo Finance· 1 month agoRoche Holding AG RHHBY announced that the late-stage study evaluating its marketed drug, Columvi...
Biotech Stock Roundup: GERN, CRNX Gain on Updates, BMY's CAR T Cell Therapy News & More
Zacks via Yahoo Finance· 2 months agoIt was a busy week for the biotech sector with lots of study data readouts and regulatory approvals....
Bristol Myers cell therapy wins first-of-its-kind approval
BioPharma Dive via Yahoo Finance· 2 months agoSold as Breyanzi, the therapy is now cleared for use in certain adults with hard-to-treat forms of...
FATE Q2 Earnings Beat on Lower Expenses, Revenues Miss
Zacks via Yahoo Finance· 10 months agoFate Therapeutics FATE reported a loss of 54 cents per share in the second quarter of 2023, narrower...
Eli Lilly (LLY) Lymphoma Candidate Pirtobrutinib Gets FDA Nod
Zacks via Yahoo Finance· 1 year agoEli Lilly and Company LLY announced that the FDA, under an accelerated approval pathway, approved...
US FDA expands use of Bristol Myers' cancer therapy (March 14)
Reuters via Yahoo News· 2 months agoThe U.S. Food and Drug Administration on Thursday expanded the use of Bristol Myers Squibb's cell...
Cancer Drug Approval? 3 Biotech Stocks on the Brink of Breakthroughs
InvestorPlace via Yahoo Finance· 8 months agoAutologous chimeric antigen receptor T cell therapy is 0ne of the most promising, relatively new...
Ads
related to: b-cell chronic lymphocytic leukemia treatment